I couldn't have put it better myself. There is a right way and a wrong way to perform a rs. At .0001, no orofits and a failed product with no shareholder loyalty, it's kind of "in your face" at this point. It's the "classroom model" of the pump n' dump scenario. It's pretty transparent and obvious at this point. Also, it's dissappointing.
As time goes on, everything becomes clear to me at least. The company failed due to a severe lack of business experience. It's downright sloppy. These guys REALLY "jumped in" the deep end of the pool when they didn't know how to swim. They tried, couldn't make it work, and scraped all the profits they could throughout the process so it was eventually worth it to them in the end...at our expense of course.
In my opinion, it was simple economics. They gambled on a their "nifty" little pain killing medicine, but they couldn't offer it cheap enough to compete with mainstream medicine. At $20 a bottle, for a small number of pills that very few states would legally allow for over-the-counter canabis sales, they had no chance. It was too expensive, and the release of the product nationally was way too early. I bet ya' in 5 years, when the canabis can be extracted and inserted INTO the product cheaper, you might see the medicine soldnin every pharmacy at the price ofna bottle of Tylenol, $3???
I think they pushed the whole "migraine" advertising campaign BECAUSE they couldn't produce and sell it cheaper than $20. It's just canabanoid! Another company is doing THE EXACT same thing at a much smallef level. You can can get Darmanol at the same price ($25) sold in a few states by a different company right now. The difference is, it's done on a much smaller level. Besidez, you only have a handfull of states to work with since we're at the beginning of the mmj phenomenon.
In short, these guys were trying to bite into the industry and bit off more than they could chew. Look out for new executives to be hired and old ones to be fired. It MIGHT be a silved lining.
News 
Market Data 
Discover 
